AUTHOREA
Log in
Sign Up
Browse Preprints
LOG IN
SIGN UP
Yoshihisa Shitara
Head of PKDM-Japan, Sanofi
Tokyo
Public Documents
1
May 23, 2023
Dose selection in phase I trials: a review of development programs from approved drug...
Rudiger Kaspera and Yoshihisa Shitara